Glycemic index and colorectal carcinogenesis

European Journal of Epidemiology

Volumn 19, Issue 5, 2004, Pages 405-407

  Giovannucci, Edward ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FRUCTOSAMINE; HEMOGLOBIN A1C; INSULIN; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

CANCER RISK; CARCINOGENESIS; CLINICAL FEATURE; CLINICAL TRIAL; COLON ADENOMA; COLORECTAL CANCER; DIABETES MELLITUS; DIET; DIET THERAPY; DISEASE MARKER; GLUCOSE BLOOD LEVEL; GLYCEMIC INDEX; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; IMMOBILIZATION; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; META ANALYSIS; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; OBESITY; RISK ASSESSMENT; RISK FACTOR;

ADENOMA; BLOOD GLUCOSE; COLORECTAL NEOPLASMS; FRUCTOSAMINE; GLYCEMIC INDEX; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; METABOLIC SYNDROME X; RISK FACTORS;

EID: 3543002843     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:EJEP.0000027379.98449.d9     Document Type: Note

References (28)

1. Misciagna G, De Michele G, Guerra V, Cisternino AM, Di Leo A, Freudenheim JL & The INTEROSP Group. Serum fructosamine and colorectal adenomas. Eur J Epidemiol 2004; 19: 425-432.
2. Sakkinen PA, Wahl P, Cushman M, Lewis MR, Tracy RP. Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am J Epidemiol 2000; 152: 897-907.
3. McKeown-Eyssen G. Epidemiology of colorectal cancer revisited: Are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev 1994; 3: 687-695.
4. Giovannucci E. Insulin and colon cancer. Cancer Causes Control 1995; 6: 164-179.
5. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: A review of the evidence. J Nutr 2001; 131: 3109S-3120S.
6. Nilsen TI, Vatten LJ. Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: Exploring the hyperinsulinaemia hypothesis. Br J Cancer 2001; 84(3): 417-422.
7. Trevisan M, Liu J, Muti P, Misciagna G, Menotti A, Fucci F. Markers of insulin resistance and colorectal cancer mortality. Risk Factors and Life Expectancy Research Group. Cancer Epidemiol Biomarkers Prev 2001; 10: 937-941.
8. Saydah SH, Loria CM, Eberhardt MS, Brancati FL. Abnormal glucose tolerance and the risk of cancer death in the United States. Am J Epidemiol 2003; 157: 1092-1100.
9. Colangelo LA, Gapstur SM, Gann PH, Dyer AR, Liu K. Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev 2002; 11: 385-391.
10. Schoen RE, Tangen CM, Kuller LH, et al. Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst 1999; 91: 1147-1154.
11. Yamada K, Araki S, Tamura M, et al. Relation of serum total cholesterol, serum triglycerides and fasting plasma glucose to colorectal carcinoma in situ. Int J Epidemiol 1998; 27: 794-798.
12. Teramukai S, Rohan T, Lee KY, Eguchi H, Oda T, Kono S. Insulin-like growth factor (IGF)-I, IGF-binding protein-3 and colorectal adenomas in Japanese men. Jpn J Cancer Res 2002; 93: 1187-1194.
13. Saydah SH, Platz EA, Rifai N, Pollak MN, Brancati FL, Helzlsouer KJ. Association of markers of insulin and glucose control with subsequent colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2003; 12: 412-418.
14. Platz EA, Hankinson SE, Rifai N, Colditz GA, Speizer FE, Giovannucci E. Glycosylated hemoglobin and risk of colorectal cancer and adenoma (United States). Cancer Causes Control 1999; 10: 379-386.
15. Olufemi S, Talwar D, Robb DA. The relative extent of glycation of haemoglobin and albumin. Clin Chim Acta 1987; 163: 125-136.
16. Ryle AJ, Davie S, Gould BJ, Yudkin JS. A study of the effect of diet on glycosylated haemoglobin and albumin levels and glucose tolerance in normal subjects. Diabet Med 1990; 7: 865-870.
17. Brand-Miller J, Hayne S, Petocz P, Colagiuri S. Low-glycemic index diets in the management of diabetes: A meta-analysis of randomized controlled trials. Diabetes Care 2003; 26: 2261-2267.
18. 1c and fructosamine: Evidence for a glycosylation gap and its relation to diabetic nephropathy. Diabetes Care 2003; 26: 163-167.
19. Higginbotham S, Zhang ZF, Lee IM, et al. Dietary glycemic load and risk of colorectal cancer in the Women's Health Study. J Natl Cancer Inst 2004; 96: 229-233.
20. Terry PD, Jain M, Miller AB, Howe GR, Rohan TE. Glycemic load, carbohydrate intake, and risk of colorectal cancer in women: A prospective cohort study. J Natl Cancer Inst 2003; 95: 914-916.
21. Holt SH, Miller JC, Petocz P. An insulin index of foods: The insulin demand generated by 1000-kJ portions of common foods. Am J Clin Nutr 1997; 66: 1264-1276.
22. Slattery ML, Boucher KM, Caan BJ, Potter JD, Ma KN. Eating patterns and risk of colon cancer. Am J Epidemiol 1998; 148: 4-16.
23. Fung TT, Rimm EB, Spiegelman D, et al. The association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk. Am J Clin Nutr 2001; 73: 61-67.
24. Fung T, Hu FB, Fuchs CS, et al. Major dietary patterns and the risk of colorectal cancer in women. Arch Intern Med 2003; 163: 309-314.
25. Luceri C, Caderni G, Lancioni L, et al. Effects of repeated boluses of sucrose on proliferation and on AOM-induced aberrant crypt foci in rat colon. Nutr Cancer 1996; 25: 187-196.
26. Ma J, Giovannucci E, Pollak M, et al. A prospective study of plasma C-peptide and colorectal cancer risk in men. J Natl Cancer Inst (in press).
27. Kaaks R, Toniolo P, Akhmedkhanov A, et al. Serum C-peptide, insulin-like growth factor (IGF)-1, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 2000; 92: 1592-1600.
28. Palmqvist R, Stattin P, Rinaldi S, et al. Plasma insulin, IGF-binding proteins-1 and -2 and risk of colorectal cancer: A prospective study in Northern Sweden. Int J Cancer 2003; 107: 89-93.